ZJ, N., CY, G., MA, Z., CK, L., JC, L., HS, N., & JS, T. (2026). Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health. Probiotics and antimicrobial proteins, 18(3), 4299. https://doi.org/10.1007/s12602-025-10773-2
Chicago Style (17th ed.) CitationZJ, Ng, Gan CY, Zarin MA, Lee CK, Lan JC, Ng HS, and Tan JS. "Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus Mutans in Oral Health." Probiotics and Antimicrobial Proteins 18, no. 3 (2026): 4299. https://doi.org/10.1007/s12602-025-10773-2.
MLA (9th ed.) CitationZJ, Ng, et al. "Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus Mutans in Oral Health." Probiotics and Antimicrobial Proteins, vol. 18, no. 3, 2026, p. 4299, https://doi.org/10.1007/s12602-025-10773-2.